Socially Determined is leading the integration of health and social care through social risk analytics. Our SocialScape® platform, social risk data, and industry-leading solutions empower health systems, health plans, and other risk-bearing organizations to manage risk, improve outcomes, and advance healthcare for all. For more information, please visit sociallydetermined.com

BOC Sciences is a trusted CRO partner specializing in targeted nanodelivery platforms and high-quality components for drug delivery. Our comprehensive portfolio includes PEGs, lipids, phospholipids, small molecule ligands, CPPs, and aptamers—enabling the advanced delivery of small molecule drugs, peptide therapeutics, mRNA, and oligonucleotide-based drugs. With deep expertise in bioconjugation, nanocarrier engineering, and targeted delivery strategies, we offer both catalog and custom solutions to meet the evolving demands of modern therapeutics. BOC Sciences is ISO certified and provides GMP-grade materials suitable for Phase I clinical trials. From early discovery to clinical development, we are committed to accelerating your innovation in targeted drug delivery.

For more information please visit https://www.steripack.com/

Smithers supports medical device and pharmaceutical manufacturers with expert, independent testing across the product development cycle, from concept and materials to packaging and distribution. Our team provides guidance and data to meet FDA, EMA, MHRA, USP, ASTM, and ISO standards. With deep expertise and broad capabilities, Smithers helps bring innovative, high-performing products to market efficiently.

Ashland is a focused additives and specialty ingredients company serving customers in pharmaceuticals, food and beverage and other consumer and industrial markets. Approximately 2,960 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries.

Captisol is a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY® (remdesivir) and KYPROLIS®️ (carfilzomib) to help solubilize & stabilize difficult to deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency. Captisol has been used in therapeutics across many routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation, and dermal. It is prepared by an all-aqueous process and distributed world-wide.

Bionanopharma, a high-tech drug delivery company majority-owned by Insud Pharma, operates a unique GMP-certified facility with industrial-scale capacity from early-stage development to commercial manufacturing. Our proprietary room-temperature processing enables high-concentration mAb formulations, enhances bioavailability of BCS Class II–IV molecules, and supports customized release profiles across diverse administration routes: SC, oral, nasal, inhalation, LAI, transdermal, sublingual and ophthalmic patches.

ViaNautis is pioneering precision genetic medicines with polyNaut®, a polymer nanovesicle platform enabling targeted delivery beyond the liver. Our programs span CNS, I&I (autoimmunity), and CF - developing safe, redosable products. Based in Cambridge, UK, we advance partnerships to unlock new therapeutic frontiers.

Maxis AI is a leading provider of Agentic AI-driven clinical trials data analytics that empowers customers with smarter, faster insights to achieve superior clinical outcomes. With over 3,300 clinical trials in cloud across small to large life sciences organizations, our source-agnostic platform is a single-source-of-truth for clinical study information.

Headquartered in Edison, NJ, with employees around the globe, Maxis AI offers unique value with over 20 years of domain expertise and dedication to delivering innovative and user-friendly experiences. Whether it’s accelerating AI in clinical trials, improving drug development timelines, or revolutionizing clinical data management to outcome optimization, our AI solutions directly address modern challenges in ways that are intuitive and actionable. Discover more at www.maxisai.com.

DEEP Measures accelerates the utilization of digital measures by helping pharma companies, technology developers, and academic institutions create novel digital endpoints. Our model ensures that such measures are designed to be patient-focused and fit-for-purpose from the start, with definitions and evidence required for regulatory qualification and use in clinical trials. For more information, please visit https://www.deepmeasures.health/

Espresso is a fast & smart clinical trial monitoring solution that transforms operational complexity into real-time control, delivering complete site oversight every day.

Our AI-powered digital workers continuously scan reports, detect protocol deviations, and auto-deploy corrective actions—turning signal detection into problem resolution in hours, not weeks.

The result? ClinOps teams become exponentially more effective—with reduced risk, consistent quality, and less day-to-day burden. Smarter, faster, more resilient trials, with zero integration required.

Kenox Pharmaceuticals (Princeton, NJ) is a contract development, manufacturing, and testing organization specializing in nasal, inhalation, and ophthalmic products. We offer early-stage research and development through GMP fill-finish and testing of non-sterile and sterile drug-device combination products for Phase I and II clinical trials. Our unique value lies in our deep expertise, broad experience, and flexibility in managing diverse device technologies, including Soft Mist inhalers, to support innovative drug delivery solutions.